Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 10.15 | 50.3722084367 | 20.15 | 31.66 | 20.08 | 323393 | 26.75960149 | CS |
4 | 11.1 | 57.8125 | 19.2 | 31.66 | 17.1804 | 140613 | 23.82704763 | CS |
12 | 14.43 | 90.9262759924 | 15.87 | 31.66 | 15.5 | 62748 | 21.92761768 | CS |
26 | 13.4 | 79.2899408284 | 16.9 | 31.66 | 15.0001 | 59688 | 21.40850919 | CS |
52 | 13.4 | 79.2899408284 | 16.9 | 31.66 | 15.0001 | 59688 | 21.40850919 | CS |
156 | 13.4 | 79.2899408284 | 16.9 | 31.66 | 15.0001 | 59688 | 21.40850919 | CS |
260 | 13.4 | 79.2899408284 | 16.9 | 31.66 | 15.0001 | 59688 | 21.40850919 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관